Wang et al. (2020a) demonstrated that LINC01614 is a highly cancer-associated oncogene and can serve as a prognostic biomarker for multiple types of tumors (Wang et al., 2020a). LncRNAs have been reported to regulate distinct immune cell functions in the tumor immune microenvironment (TIME) through diverse biological processes (Park et al., 2022). This evidence concerns the gene LINC01614 and neoplasm.